Last Price
2.18
Today's Change
+0.115 (5.55%)
Day's Change
2.09 - 2.21
Trading Volume
193,058
Market Cap
31 Million
Shares Outstanding
14 Million
Avg Volume
1,130,296
Avg Price (50 Days)
2.08
Avg Price (200 Days)
3.20
PE Ratio
-0.25
EPS
-8.86
Earnings Announcement
08-Nov-2024
Previous Close
2.07
Open
2.10
Day's Range
2.09 - 2.216
Year Range
0.771 - 23.9
Trading Volume
193,263
1 Day Change
5.56%
5 Day Change
-1.13%
1 Month Change
12.05%
3 Month Change
-28.12%
6 Month Change
30.84%
Ytd Change
-83.45%
1 Year Change
-88.79%
3 Year Change
-93.79%
5 Year Change
-97.05%
10 Year Change
-97.05%
Max Change
-97.05%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.